SUARDI, NAZARENO
 Distribuzione geografica
Continente #
AS - Asia 5.934
NA - Nord America 4.657
SA - Sud America 2.332
EU - Europa 1.659
AF - Africa 161
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 3
AN - Antartide 1
Totale 14.757
Nazione #
US - Stati Uniti d'America 4.510
SG - Singapore 2.446
BR - Brasile 1.965
HK - Hong Kong 991
CN - Cina 986
VN - Vietnam 607
TR - Turchia 307
RU - Federazione Russa 304
FR - Francia 299
GB - Regno Unito 254
IE - Irlanda 241
AR - Argentina 165
IT - Italia 159
IN - India 131
DE - Germania 112
BD - Bangladesh 93
IQ - Iraq 74
EC - Ecuador 61
ID - Indonesia 60
MX - Messico 60
SE - Svezia 52
ZA - Sudafrica 50
FI - Finlandia 48
UA - Ucraina 40
CA - Canada 38
CO - Colombia 37
SA - Arabia Saudita 33
PK - Pakistan 31
ES - Italia 29
PY - Paraguay 26
CL - Cile 24
MA - Marocco 20
PL - Polonia 20
TN - Tunisia 19
KE - Kenya 18
NL - Olanda 18
AT - Austria 17
JP - Giappone 17
VE - Venezuela 17
JO - Giordania 16
UY - Uruguay 16
UZ - Uzbekistan 16
EG - Egitto 15
AE - Emirati Arabi Uniti 14
PE - Perù 14
PH - Filippine 14
NP - Nepal 13
AZ - Azerbaigian 11
KZ - Kazakistan 11
AU - Australia 10
CZ - Repubblica Ceca 10
DZ - Algeria 10
BH - Bahrain 9
HN - Honduras 8
JM - Giamaica 8
LB - Libano 8
PT - Portogallo 8
OM - Oman 7
SN - Senegal 7
AL - Albania 6
BO - Bolivia 6
ET - Etiopia 6
IL - Israele 6
TT - Trinidad e Tobago 6
BE - Belgio 5
CH - Svizzera 5
DO - Repubblica Dominicana 5
NI - Nicaragua 5
RS - Serbia 5
AM - Armenia 4
LT - Lituania 4
LV - Lettonia 4
SY - Repubblica araba siriana 4
AO - Angola 3
CI - Costa d'Avorio 3
GE - Georgia 3
GT - Guatemala 3
HU - Ungheria 3
KW - Kuwait 3
NG - Nigeria 3
PR - Porto Rico 3
XK - ???statistics.table.value.countryCode.XK??? 3
BB - Barbados 2
BG - Bulgaria 2
BW - Botswana 2
CR - Costa Rica 2
GR - Grecia 2
KG - Kirghizistan 2
MK - Macedonia 2
PA - Panama 2
PS - Palestinian Territory 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
TH - Thailandia 2
TW - Taiwan 2
AQ - Antartide 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CG - Congo 1
Totale 14.734
Città #
Singapore 1.209
Hong Kong 991
The Dalles 497
Princeton 484
Ashburn 425
San Jose 407
New York 292
Istanbul 280
Lauterbourg 269
Dublin 243
Ho Chi Minh City 211
Beijing 151
Fairfield 150
Los Angeles 143
Moscow 138
Hanoi 133
Redondo Beach 133
São Paulo 130
Des Moines 128
San Diego 126
Wilmington 120
London 106
Buffalo 94
Seattle 86
Orem 66
Rio de Janeiro 58
Woodbridge 55
Chicago 52
Dallas 51
Houston 41
Santa Clara 38
Belo Horizonte 36
Brasília 36
Cambridge 34
Porto Alegre 33
Helsinki 30
Chennai 28
Curitiba 28
Munich 28
Romola 28
Chandler 27
Guayaquil 27
Salvador 27
Shanghai 27
Milan 26
Campinas 24
Biên Hòa 22
Erbil 22
Manchester 22
Johannesburg 21
Guarulhos 20
Nuremberg 20
Warsaw 20
Buenos Aires 19
Haiphong 19
Tianjin 19
Baghdad 18
Da Nang 18
Fortaleza 18
San Francisco 18
Goiânia 17
Hải Dương 17
Thái Bình 17
Council Bluffs 16
Manaus 16
Quito 16
West Jordan 16
Atlanta 15
Nairobi 15
Recife 15
Riyadh 15
Amman 14
Bắc Giang 14
Campo Grande 14
Dhaka 14
Ankara 13
Jakarta 13
Lahore 13
Montevideo 13
Montreal 13
Norwalk 13
Salt Lake City 13
São José do Rio Preto 13
Tokyo 13
Turku 13
Bogotá 12
Denver 12
Duque de Caxias 12
Ninh Bình 12
Osasco 12
Stockholm 12
Baku 11
Brooklyn 11
Caxias do Sul 11
Düsseldorf 11
Guangzhou 11
Juiz de Fora 11
New Delhi 11
Poplar 11
Ribeirão Preto 11
Totale 8.554
Nome #
Salvage therapy of small volume prostate cancer nodal failures: A review of the literature 173
The CDK Inhibitor Dinaciclib Improves Cisplatin Response in Nonseminomatous Testicular Cancer: A Preclinical Study 109
Pathological Complete Response to Pembrolizumab plus Axitinib Combination following Serious Immune-Related Adverse Events in an Advanced Renal Cell Carcinoma Patient with a History of Rheumatoid Arthritis 95
A proposal of a new nomogram for predicting upstaging in contemporary D’Amico low-risk prostate cancer patients 94
A proposal of a new nomogram for predicting upstaging in contemporary D'Amico low-risk prostate cancer patients 87
Whole-body Diffusion-weighted Magnetic Resonance Imaging for Assessment of the Bone Response Rate in Patients with Metastatic Hormone-sensitive Prostate Cancer Receiving Enzalutamide 83
A nomogram for staging of exclusive nonobturator lymph node metastases in men with localized prostate cancer 83
A Multi-institutional Analysis of Perioperative Outcomes in 106 Men Who Underwent Radical Prostatectomy for Distant Metastatic Prostate Cancer at Presentation 83
68Ga-PSMA and 68Ga-DOTA-RM2 PET/MRI in Recurrent Prostate Cancer: Diagnostic Performance and Association with Clinical and Histopathological Data 81
A nomogram predicting long-term biochemical recurrence after radical prostatectomy 79
Management of osteomyelitis of the pubic symphysis following urinary fistula in patients with radiation-induced urethral strictures after prostate cancer treatment 76
A Novel Liquid Biopsy Method Based on Specific Combinations of Vesicular Markers Allows Us to Discriminate Prostate Cancer from Hyperplasia 75
Assessing Functional Outcomes of Partial Versus Radical Nephrectomy for T1b-T2 Renal Masses: Results from a Multi-institutional Collaboration 75
Assessment of HER2 protein overexpression and gene amplification in renal collecting duct carcinoma: Therapeutic implication 75
Acceptance of and discontinuation rate from erectile dysfunction oral treatment in patients following bilateral nerve-sparing radical prostatectomy 74
A Nomogram Predicting Prostate Cancer-Specific Mortality after Radical Prostatectomy 73
Evaluating Lichen Sclerosus in Phimosis: Insights From a Multidisciplinary Retrospective Study 72
Minimally invasive strategies for the treatment of prostate cancer recurrence after radiation therapy: a systematic review 72
A Preoperative Prognostic Model for Patients Treated with Nephrectomy for Renal Cell Carcinoma 69
Are Urologists Ready for Interpretation of Multiparametric MRI Findings? A Prospective Multicentric Evaluation 68
A nomogram predicting the cancer-specific mortality in patients eligible for radical cystectomy evaluating clinical data and neoadjuvant cisplatinum-based chemotherapy 68
PET/CT and Conventional Imaging for the Assessment of Neuroendocrine Prostate Cancer: A Systematic Review 67
A robotic needle driver to facilitate vescico-urethral anastomosis during laparoscopic radical prostatectomy 67
Accuracy of life tables in predicting overall survival in patients after radical prostatectomy 66
A nomogram is more accurate than a regression tree in predicting lymph node invasion in prostate cancer 66
A Detailed Analysis of the Association Between Postoperative Phosphodiesterase Type 5 Inhibitor Use and the Risk of Biochemical Recurrence After Radical Prostatectomy 66
Surgical Experience and Functional Outcomes after Laparoscopic and Robot-Assisted Partial Nephrectomy: Results from a Multi-Institutional Collaboration 65
Port-site metastasis and atypical recurrences after robotic-assisted radical cystectomy (RARC): an updated comprehensive and systematic review of current evidences 65
A nomogram predicting metastatic progression after radical prostatectomy 65
ABLATE: a score to predict complications and recurrence rate in percutaneous treatments of renal lesions 62
Salvage lymph node dissection: if yes, robotics? 62
THE RATE OF SECONDARY MALIGNANCIES AFTER RADICAL PROSTATECTOMY VERSUS EXTERNAL BEAM RADIATION THERAPY FOR LOCALIZED PROSTATE CANCER: A POPULATION-BASED STUDY ON 17,845 PATIENTS 62
Adjuvant chemotherapy for bladder cancer does not alter cancer-specific survival after cystectomy in a matched case-control study 62
Life expectancy in metastatic urothelial bladder cancer patients according to race/ethnicity 61
A critical analysis of laser prostatectomy in the management of benign prostatic hyperplasia 61
Choosing the Best Candidates for Penile Rehabilitation after Bilateral Nerve-Sparing Radical Prostatectomy 61
Combining PSA and PET features to select candidates for salvage lymph node dissection in recurrent prostate cancer 61
The Role of Prostate-specific Antigen Persistence after Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients 60
Contemporary Pathological Stage Distribution After Radical Prostatectomy in North American High-Risk Prostate Cancer Patients 60
Intensive simulation training on urological mini-invasive procedures using Thiel-embalmed cadavers: The IAMSurgery experience 59
Bladder cancer histological variants: which parameters could predict the concordance between transurethral resection of bladder tumor and radical cystectomy specimens? 59
External Validation of the European Association of Urology Recommendations for Pelvic Lymph Node Dissection in Patients Treated with Robot-Assisted Radical Prostatectomy 59
Neoadjuvant Short-term Intensive Intravesical Mitomycin C Regimen Compared with Weekly Schedule for Low-grade Recurrent Non-muscle-invasive Bladder Cancer: Preliminary Results of a Randomised Phase 2 Study 59
External beam radiotherapy and radical prostatectomy are associated with better survival in Asian prostate cancer patients 58
Impact of Lymph Node Dissection on Cancer Specific Survival in Patients With Upper Tract Urothelial Carcinoma Treated With Radical Nephroureterectomy 58
Perioperative and Oncologic Outcomes of Nephrectomy and Caval Thrombectomy Using Extracorporeal Circulation and Deep Hypothermic Circulatory Arrest for Renal Cell Carcinoma Invading the Supradiaphragmatic Inferior Vena Cava and/or Right Atrium 58
The Number of Cores at First Biopsy May Suggest the Need for a Confirmatory Biopsy in Patients Eligible for Active Surveillance-Implication for Clinical Decision Making in the Real-life Setting 58
Survival after Radical Prostatectomy versus Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer 57
Comparison of nomograms with other methods for predicting outcomes in prostate cancer: A critical analysis of the literature 57
Underestimation of positron emission tomography/computerized tomography in assessing tumor burden in prostate cancer nodal recurrence: Head-to-head comparison of 68Ga-PSMA and 11C-choline in a large, multi-institutional series of extended salvage lymph node dissections 57
Diagnostic accuracy of fully hybrid [68Ga]Ga-PSMA-11 PET/MRI and [68Ga]Ga-RM2 PET/MRI in patients with biochemically recurrent prostate cancer: a prospective single-center phase II clinical trial 56
Age-adjusted validation of the most stringent criteria for active surveillance in low-risk prostate cancer patients 56
When to perform preoperative chest computed tomography for renal cancer staging 56
Technologies for image-guided surgery for managing lymphatic metastases in prostate cancer 56
The Surgical Learning Curve for Biochemical Recurrence After Robot-assisted Radical Prostatectomy 55
Intravesical Therapy for Non-Muscle-Invasive Bladder Cancer: What Is the Real Impact of Squamous Cell Carcinoma Variant on Oncological Outcomes? 55
What is the optimal definition of misclassification in patients with very low-risk prostate cancer eligible for active surveillance? Results from a multi-institutional series 55
Age at diagnosis is a determinant factor of renal cell carcinoma-specific survival in patients treated with nephrectomy 55
More Extensive Pelvic Lymph Node Dissection Improves Survival in Patients with Node-positive Prostate Cancer 55
Current Standard Technique for Modern Flexible Ureteroscopy: Tips and Tricks 55
Combination of Adjuvant Hormonal and Radiation Therapy Significantly Prolongs Survival of Patients With pT2-4 pN+ Prostate Cancer: Results of a Matched Analysis 55
A novel tool to assess the risk of urinary incontinence after nerve-sparing radical prostatectomy 55
Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection in Patients with Locally-advanced Prostate Cancer 55
Micropapillary bladder cancer: an evolving biology 54
The Number of Cores at First Biopsy May Suggest the Need for a Confirmatory Biopsy in Patients Eligible for Active Surveillance-Implication for Clinical Decision Making in the Real-life Setting REPLY 54
Identifying the Optimal Candidate for Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer: Results from a Large, Multi-institutional Analysis 54
Selecting the Optimal Candidate for Adjuvant Radiotherapy After Radical Prostatectomy for Prostate Cancer: A Long-term Survival Analysis 54
Increasing Rate of Noninterventional Treatment Management in Localized Prostate Cancer Candidates for Active Surveillance: A North American Population-Based Study 54
Immuno-oncology therapy in metastatic bladder cancer: A systematic review and network meta-analysis 53
Adenocarcinoma of the Bladder: Assessment of Survival Advantage Associated With Radical Cystectomy and Comparison With Urothelial Bladder Cancer 53
Preoperative Hypogonadism Is Not an Independent Predictor of High-Risk Disease in Patients Undergoing Radical Prostatectomy 53
Poor overall survival in septa- and octogenarian patients after radical prostatectomy and radiotherapy for prostate cancer: A population-based study of 6183 men 53
Improving the preservation of the urethral sphincter and neurovascular bundles during open radical retropubic prostatectomy 53
Prostate Saturation Biopsy following a First Negative Biopsy: State of the Art 53
Re: Novel Classification for Upper Tract Urothelial Carcinoma to Better Risk-stratify Patients Eligible for Kidney-sparing Strategies: An International Collaborative Study 53
The prognostic role of staging [18F]PSMA-1007 PET/CT volumetric and dissemination features in prostate cancer 52
Extended pelvic lymph node dissection in prostate cancer: a 20-year audit in a single center 52
Reply to Ian Beckley and Masood A. Khan's letter to the editor Re: Felix K.-H. Chun, Thomas Steuber, Andreas Erbersdobler, et al. development and internal validation of a nomogram predicting the probability of prostate cancer gleason sum upgrading between biopsy and radical prostatectomy pathology. Eur Urol 2006;49 : 820-26 52
Assessment of the Minimum Number of Lymph Nodes Needed to Detect Lymph Node Invasion at Radical Nephroureterectomy in Patients With Upper Tract Urothelial Cancer 52
Currently Used Criteria for Active Surveillance in Men With Low-risk Prostate Cancer An Analysis of Pathologic Features 52
Overall Survival of Metastatic Prostate Cancer Patients According to Location of Visceral Metastatic Sites 52
Metastasis Within Three Years from Radical Nephroureterectomy as a Potential Surrogate for Overall Survival 51
Response to Re: External beam radiotherapy and radical prostatectomy are associated with better survival in Asian prostate cancer patients 51
Genitourinary manifestations of Lynch syndrome in the urological practice 51
General versus spinal anesthesia in patients undergoing radical retropubic prostatectomy: Results of a prospective, randomized study 51
Cytoreductive Radical Prostatectomy in Men with Prostate Cancer and Skeletal Metastases 51
Identifying candidates for super-extended staging pelvic lymph node dissection among patients with high-risk prostate cancer 51
Survival of patients with clear cell renal carcinoma according to number and location of organ-specific metastatic sites 50
Impact of chronic prostatitis-like symptoms on the quality of life in a large group of men 50
Staging lymphadenectomy in renal cell carcinoma must be extended: a sensitivity curve analysis 50
Association Between Prostate Imaging Reporting and Data System (PI-RADS) Score for the Index Lesion and Multifocal, Clinically Significant Prostate Cancer 50
Holmium laser enucleation versus open prostatectomy for benign prostatic hyperplasia: An inpatient cost analysis 50
Evaluating the effect of time from prostate cancer diagnosis to radical prostatectomy on cancer control: Can surgery be postponed safely? 50
Toxicities associated with the administration of sorafenib, sunitinib, and temsirolimus and their management in patients with metastatic renal cell carcinoma 50
Long-Term Follow-up of Patients with Prostate Cancer and Nodal Metastases Treated by Pelvic Lymphadenectomy and Radical Prostatectomy: The Positive Impact of Adjuvant Radiotherapy 50
Lymphatic spread of nodal metastases in high-risk prostate cancer: The ascending pathway from the pelvis to the retroperitoneum 50
Complications and other surgical outcomes associated with extended pelvic lymphadenectomy in men with localized prostate cancer 50
The association of the type and number of D'Amico high-risk criteria with rates of pathologically non-organ-confined prostate cancer 50
The association of type and number of high-risk criteria with cancer-specific mortality in prostate cancer patients treated with radical prostatectomy 49
Radiation therapy after radical prostatectomy is associated with higher other-cause mortality 49
Totale 6.168
Categoria #
all - tutte 133.696
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 133.696


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214 0 0 0 0 0 0 0 0 0 3 1 0
2021/20221.305 1 3 0 0 0 560 38 70 60 195 131 247
2022/2023668 242 1 0 3 13 258 0 11 99 5 22 14
2023/20241.371 16 9 23 25 19 244 75 6 593 22 12 327
2024/20253.684 9 4 43 392 654 316 178 42 429 449 774 394
2025/20267.940 641 1.322 916 1.770 567 302 1.085 283 441 613 0 0
Totale 15.073